Designing Longevity
Skip to main content
Strong EvidencePeptide

Insulin lispro

Rapid-acting insulin analogue

Last updated: November 2026
Share:

Insulin lispro is a rapid-acting insulin used to manage blood sugar in people with diabetes. Humalog has multiple presentations. The Humalog U-100 KwikPen, a U-100 vial and a U-200 pen can have different prescription, dispensing and coverage rules.

Evidence Level: Strong Evidence

Multiple large human trials, FDA approval, established safety profile

Regulatory Status: FDA-approved Humalog is indicated to improve blood sugar control in adults and children with diabetes.

How It Works

Insulin helps tissues take up glucose and reduces the amount of glucose the liver releases into the blood.

Potential Benefits

  • Its FDA label covers blood sugar control in diabetes.

Risks & Considerations

  • Changes in insulin type, strength, device or manufacturer can raise the risk of high or low blood sugar. Discuss any switch with the prescribing team.

Sources and regulatory records

Disclaimer: This information is for educational purposes only and is not medical advice. Many peptides discussed are not FDA-approved for human use. Always consult with a qualified healthcare provider before starting any treatment. Evidence levels and regulatory status can change, this content was last updated November 2026.

Found this helpful? Share it or save it for later.

Share:

See a problem or outdated information? Tell us.